Renaissance Capital logo

Aesthetic device maker Candela Medical withdraws $250 million IPO

September 2, 2022

Candela Medical, which makes energy-based medical devices for aesthetic procedures, withdrew its plans for an initial public offering on Friday. It had planned to raise $250 million by offering 14.7 million shares at a price range of $16 to $18, but postponed in October 2021.

The Marlborough, MA-based company was founded in 2010 and booked $390 million in revenue for the 12 months ended June 30, 2021. It had planned to list on the Nasdaq under the symbol CDLA. BofA Securities, Goldman Sachs, Barclays, Baird, Canaccord Genuity, and Stifel were set to be the joint bookrunners on the deal.